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By histological and ultrastructural criteria, most of
the cells forming the tumour masses in basal cell
carcinoma (BCC) resemble the normal epidermal
basal cells from which they are thought to arise
(reviewed by Pollack, 1982). This common locally
invasive skin tumour is further characterised by
extensive remodelling of the surrounding connective
tissue (Getzrow, 1966; Pinkus, 1979; Delpech et al.,
1982), and by the absence of bullous pemphigoid
antigen from the basement membrane zone (Stanley
et al., 1982a).
In this and other laboratories, the profile of
lectin binding sites has been found to change in a
characteristic manner as normal epidermal keratino-
cytes differentiate (Nemanic et al., 1983; Bell &
Skerrow, 1984). We have recently shown that in
the benign hyperproliferative skin disease, psoriasis,
this profile is altered in such a way as to suggest
that the lectins BSAI, UEAI and PNA are specific
markers for defective keratinocyte differentiation
(Bell & Skerrow, 1985). A similar conclusion has
been drawn from studies on the effect of retinoids
on the lectin binding properties of normal skin in
organ culture (Nemanic et al., 1982). Lectins there-
fore constitute sensitive probes for changes in the
display during normal and pathological epidermal
differentiation ofglycoconjugates, theabnormal inter-
actions of which are thought to be important in
tumour aetiology. In addition, groups of lectins
have been identified which bind to components of
the basement membrane zone and dermis (Bell &
Skerrow, 1984).
In numerous biochemical studies, notably on
melanoma cell lines, lectins have detected
abnormalities in the complement of glycoconjugates
displayed at tumour cell surfaces, some of which
are associated with malignancy (reviewed by
Nicolson, 1982). In the case of keratinocyte
tumours, there is currently a single report of the
binding of Concanavalin A to fixed and paraffin
embedded tissue (Louis et al., 1981). This paper
describes the binding profile of a wide range of
lectins to frozen sections of basal cell carcinoma:
alterations were detected in the epithelium, stroma
and basement membrane zone.
A total of 19 histologically diagnosed basal cell
carcinomas were examined, with an average of 12
tumours being stained with each lectin. All
specimens were taken from the same histological
type of BCC: solid nodular tumours from the facial
region. They were immediately snap frozen and
stored at -20°C until required. Details of the
methodology, and the preferred source for each
lectin, are given in Bell & Skerrow (1984).
Unless otherwise specified, the staining patterns
described below were found in all the tumours
studied.
Bandeiraea simplicifolia agglutinin I (D-galactosyl,
Figure la). This lectin, which reacts with the
normal granular layer, did not bind to tumour cell
surfaces. Globules of fluorescence were seen within
some nodules in 3 out of 10 tumours. The faint fine
linear reaction of BSAI with the normal BMZ was
replaced by an intensely staining band of variable
thickness with occasional discontinuities.
Ulex europaeus agglutinin (L-fucosyl, Figure lb). In
the overlying epidermis, UEAI staining retained its
normal distribution throughout the upper spinous
and granular layers, whereas tumour epithelium
was negative throughout. The absence of reaction
in BMZ and stroma, and the intense staining of
capillaries, was identical in normal tissue and in
tumour.
Bandeiraea simplicifolia agglutinin II (N-acetyl-
glucosaminyl, Figure lc). Eight out of 11 tumours
exhibited an intracellular speckled staining, most
noticeable toward tumour margins, and a mid-
epidermal staining in the overlying epidermis. In
normal tissue, this speckled staining is restricted
to the vicinity of hair follicles and has been shown
to be specific for glycogen (Bell & Skerrow, 1984).
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Appearance of more widespread BSAII reactivity is
also seen in psoriatic epidermis (Bell & Skerrow,
1985) and glycogen is known to appear in normal
basal cells after they have been induced to
hyperproliferate following injury (Freinkel, 1983). It
is therefore probable that the increased BSAII
staining of tumour cells reflects their high
proliferation rate.
Peanut agglutinin (fl-D-galactose (1-4)-N-acetyl-
galactosaminyl, Figures Id, e). Patches of
fluorescence were seen in 5 out of 17 tumours,
corresponding to regions of differentiation or
necrosis (Figure Id). In general, however, tumour
cell surfaces reacted slightly with PNA, to the same
extent as adjacent normal basal cells. This was seen
particularly clearly where the tumour was
continuous with overlying epidermis (Figure le). In
contrast to the normal faint BMZ reaction, and the
absence of staining in the dermis, the staining by
PNA of the stroma surrounding each tumour
nodule was intense.
Helix pomatia agglutinin (a-N-acetylgalactosaminyl,
Figure If). The pattern of staining was similar to
that of PNA.
Concanavalin A (a-D-mannosyl/a-D-glycosyl, Figure
lg). Con A gave an overall faint staining of normal
epidermis and a very intense reaction with BMZ
and dermis in both normal and tumour tissue.
Epithelial cells in BCC were stained with a greater
intensity than overlying epidermis.
Wheat germ agglutinin (P-N-acetylglucosaminyl
n/N-acetylneuraminyl, Figures lh,j). This lectin
stained tumour cells to the extent as normal basal
cells. Relatively increased staining of more
differentiated areas was seen when WGA was
partially blocked with N-acetylglucosamine which
preferentially diminishes normal basal cell staining
(Figure li).
Succinylated wheat germ agglutinin (fi-N-acetyl-
glucosaminyl)n, Figure lj). sWGA reacted with
tumour cells to the same extent as normal basal
cells and faintly with both normal dermis and
stromal tissue.
Soy bean agglutinin (not illustrated) No reaction
was seen of tumour epithelial or stromal
components with SBA, which reacts with normal
suprabasal epidermal cells and with blood vessels.
The most striking abnormalities detected by
lectins in BCC are in the basement membrane zone
and the stroma surrounding tumour nodules.
Compared with the faint linear staining of the
normal BMZ by BSAI, this lectin binds to a broad,
intensely reactive band surrounding each tumour
nodule (Figure la). This band is of variable width
and shows occasional discontinuities. Globular
deposits of BSAI-positive material are also present
within the tumour nests (Figure la). A similar
distribution of BMZ components within tumour
nodules has been shown for laminin, fibronectin,
type IV collagen and bullous pemphigoid antigen,
all of which are associated with saccharide moieties
(Weber et al., 1982; Nelson et al., 1983; Van
Cauwenberge et al., 1983; Grimwood et al., 1984).
BSAI is known to bind- to laminin (Shibata et al.,
1982) which is produced by the epithelial cells
(Stanley et al., 1982b). These results therefore
constitute further evidence for the loss of control of
the normal polarized secretion and organization of
glycosylated BMZ material in BCC.
The intense zone of reaction with PNA and
HPA, not observed in normal dermis, which
surrounds each tumour nodule corresponds to a
region of newly formed stroma whose ultrastructure
and chemical composition (Getzrow, 1966; Delpech
et al., 1982; Hashimoto et al., 1972) differs from
that of normal connective tissue. The present study
extends these data by showing that this stromal
remodelling, which is characteristic of BCC, is
associated with an altered display of specific glyco-
conjugates.This may be due to the presence of new
components in this region (Delpech et al., 1982) or
to the unblocking of glycosylated residues as a
consequence of collagen degradation (Bauer et al.,
1977). Neither the changes to the BMZ nor stroma
detected by lectins in BCC are observed in other
epidermal tumours studied (C.M. Bell, unpublished
data). In basal cell papilloma the profile of
epithelial lectin binding is similar to that in BCC,
whereas in squamous cell carcinoma (SCC) lectins
confirm the histological picture of a higher and
more variable degree of differentiation. In addition,
in SCC the lectin binding sites present in the
normal BMZ are either absent or extremely faint at
tumour margins. It would appear that the
abnormalities detected by BSAI, PNA and HPA
may be specific to BCC and be of use in diagnosis
or in the assessment of excision of tumour margins.
Complete assessment of these possibilities, and of
the correlation, if any, between changes detected by
lectins and malignancy requires further examination
of different histological types of BCC and of other
malignant and premalignant skin diseases.
The epithelial component of BCC resembles
normal epidermal basal cells morphologically and
in the distribution of certain intracellular
differentiation markers (Loning et al., 1980; Merot
et al., 1983; Murphy et al., 1984; Said et al., 1984).
However, differences between BCC epithelium and
normal basal cells have been demonstrated
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1964; Weiss et al., 1983) and cell surface
components (McNutt, 1976; Brysk & Snider, 1982;
Stanley et al., 1982a,b), suggesting that the
differentiation giving rise to the BCC tumour
masses is qualitatively and not merely
quantitatively defective. The lectin binding profile
of BCC reported above extends these da'ta by
showing that the glycoconjugates displayed at the
surfaces of normal basal and tumour cells are
similar but not identical. Indication of a lower level
of differentiation is given by the binding
throughout the tumour of lectins which react with
normal basal layer (Con A, WGA, PNA (weak
reaction), and the general absence of staining with
lectins which bind to the suprabasal (SBA, sWGA,
WGA (blocked with N-acetylglucosamine), HPA
and PNA (strong reaction)) or supraspinous (BSAI,
UEAI) stages of normal epidermal differentiation.
In all cases but one the intensity of staining of
tumour masses matches that of basal layer (e.g.
Figure le): the exception is ConA, which reacts
more strongly with tumour than with neighbouring
epidermis (Figure lg). ConA has also been found to
give an increased reaction with BCC in paraffin
sections (Louis et al., 1983). In view of the low
invasiveness of BCC, it may be significant that in
many cell lines there is a good correlation between
loss of ConA receptors and increased malignancy
(reviewed by Nicolson, 1982).
Lectins demonstrate abnormalities in the
epithelial, BMZ and stromal components of BCC.
It is possible that the altered differentiation in BCC
arises from the interaction of the epithelium with
an abnormal stroma. The retention by certain adult
epithelia of responsiveness to stromal influences has
been demonstrated by recombination experiments.
Profound changes in phenotype have been shown
to result from combination of adult rodent urinary
bladder epithelium with embryonic mesenchyme
(Cunha et al., 1983; Neubauer et al., 1983). In
normal adult skin, changes in epidermal
organization can be induced by heterotypic dermis
(Briggamen & Wheeler, 1968; 1971). In the case of
BCC, the growth of transplanted tumour has been
shown to be dependent on the presence of stromal
components (Van Scott & Reinertson, 1961). The
observation that cells from BCC, devoid of
connective tissue components, show growth and
differentiation in vitro which is similar to that of
normal cells in the same system (Flaxman, 1972;
Kubilus et al., 1980) is further evidence for the
importance of stromal abnormalities. It should be
noted, however, that the differentiation of normal
epidermal cells in these systems is itself both
abnormal and incomplete, and that a detailed study
of the expression by BCC cells in vitro of the
tumour markers described above, of BMZ
components, or of lectin binding sites has not yet
been carried out. In such studies, lectins should
provide valuable probes for the altered interactions
between the epithelium, BMZ and stroma which are
believed to give rise to BCC.
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